Picture of Barinthus Biotherapeutics logo

BRNS — Barinthus Biotherapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Vaccitech Reports Full-Year 2022 Financial Results And An Update On Corporate Developments

March 24 (Reuters) - Vaccitech PLC  VACC.O :
    * VACCITECH REPORTS FULL-YEAR 2022 FINANCIAL RESULTS AND AN
UPDATE
ON CORPORATE DEVELOPMENTS
    * VACCITECH PLC: SEEN PROMISING INTERIM DATA FROM VTP-200 IN
OUR
PERSISTENT HPV PROGRAM IN Q1 OF 2023
    * VACCITECH PLC: EXPECT TO SEE FINAL DATA FROM VTP-300
BEFORE END
OF QUARTER
    * VACCITECH PLC - FY EARNINGS PER SHARE $0.14
    * VACCITECH PLC: EXPECT TO SEE FIRST PATIENT FIRST VISIT
(FPFV)
FOR VTP-850 IN NEAR TERM, ADDITIONAL DATA FOR VTP-300 LATER IN
YEAR
    * VACCITECH PLC: AS OF DECEMBER 31, 2022, CASH WAS $194.4
MILLION,
COMPARED TO $214.1 MILLION AS OF DECEMBER 31, 2021

Source text for Eikon:  ID:nGNX72ybXN 
Further company coverage:  VACC.O 

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Barinthus Biotherapeutics

See all news